Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer SUZHOU, China, Dec. 27, 2024 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK)… CISION PRNewswireDecember 30, 2024
Press ReleaseMaypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024… CISION PRNewswireDecember 30, 2024
Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726 SUZHOU, China, Dec. 30, 2024 /PRNewswire/ — Hangzhou Sino-US Huadong Medicine Co.,… CISION PRNewswireDecember 30, 2024
China strives for exchanges, mutual learning among civilizations BEIJING, Dec. 30, 2024 /PRNewswire/ — A report from People’s Daily: According… CISION PRNewswireDecember 30, 2024
Press ReleaseTaiwanese Companies Lead Innovation in AI-Powered Smart Wearables TAIPEI, Dec. 30, 2024 /PRNewswire/ — In the rapidly evolving tech landscape, smart… CISION PRNewswireDecember 30, 2024
To promote world peace, stability, and common progress of humanity BEIJING, Dec. 30, 2024 /PRNewswire/ — A report from People’s Daily: "The Vision… CISION PRNewswireDecember 30, 2024
Press ReleaseLG PRESENTS "LIVE BEYOND" WITH EXPANDED SECOND-GENERATION LG SIGNATURE LINEUP AT CES 2025 Showcasing the Evolution of the Company’s Ultra-Premium Brand, Advanced Lineup Delivers Enhanced… CISION PRNewswireDecember 30, 2024
Sobot Redefines Service Excellence at the 2024 Customer Conference Elevating Customer Experience from ‘Good’ to ‘Excellent’ Through Comprehensive Support SINGAPORE, Dec.… CISION PRNewswireDecember 30, 2024
